Concepedia

Publication | Open Access

An approach to personalized cell therapy in chronic complete paraplegia: The Puerta de Hierro phase I/II clinical trial

110

Citations

33

References

2016

Year

Abstract

Personalized cell therapy with MSCs is safe and leads to clear improvements in clinical aspects and quality of life for patients with complete and chronically established paraplegia.

References

YearCitations

Page 1